From: Severe COVID anxiety among adults in the United Kingdom: cohort study and nested feasibility trial
Factor | Category | Coefficient (95% CI) | p-value |
---|---|---|---|
Age (b) | - | -0.4 (-0.7, -0.1) | 0.02 |
Lives with vulnerable | No | 0 | 0.04 |
person | Yes | -1.1 (-2.2, -0.1) | Â |
CAS baseline | - | 0.6 (0.4, 0.8) |  < 0.001 |
GAD-7 baseline | Linear term | 1.0 (0.1, 1.8) | 0.007 |
Squared term | -0.04 (-0.07, -0.01) | Â | |
sHAI baseline (a) | - | -0.7 (-1.1, -0.3) | 0.001 |
GAD-7 reductionc | - | 0.2 (0.1, 0.3) | 0.002 |
sHAI reduction (a)c | - | 0.6 (0.1, 1.0) | 0.02 |
PHQ-9 reduction (a)c | Linear term | 0.1 (-0.5, 0.7) | 0.01 |
Squared term | 0.3 (0.1, 0.5) | Â |